These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 11772298)

  • 1. Inhaled nitric oxide in cardiology.
    Hayward CS; Macdonald PS; Keogh AM
    Expert Opin Investig Drugs; 2001 Nov; 10(11):1947-56. PubMed ID: 11772298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhaled nitric oxide in cardiology practice.
    Hayward CS; Kelly RP; Macdonald PS
    Cardiovasc Res; 1999 Aug; 43(3):628-38. PubMed ID: 10690334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nitric oxide for the evaluation and treatment of pulmonary hypertension in congenital heart disease.
    Kovalchin JP; Mott AR; Rosen KL; Feltes TF
    Tex Heart Inst J; 1997; 24(4):308-16. PubMed ID: 9456484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhaled nitric oxide versus intravenous vasodilators in severe pulmonary hypertension after cardiac surgery.
    Schmid ER; Bürki C; Engel MH; Schmidlin D; Tornic M; Seifert B
    Anesth Analg; 1999 Nov; 89(5):1108-15. PubMed ID: 10553820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of dipyridamole and inhaled nitric oxide in pediatric patients with pulmonary hypertension.
    Ziegler JW; Ivy DD; Wiggins JW; Kinsella JP; Clarke WR; Abman SH
    Am J Respir Crit Care Med; 1998 Nov; 158(5 Pt 1):1388-95. PubMed ID: 9817684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhaled nitric oxide versus aerosolized iloprost in secondary pulmonary hypertension in children with congenital heart disease: vasodilator capacity and cellular mechanisms.
    Rimensberger PC; Spahr-Schopfer I; Berner M; Jaeggi E; Kalangos A; Friedli B; Beghetti M
    Circulation; 2001 Jan; 103(4):544-8. PubMed ID: 11157720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Comparison of Inhaled Nitric Oxide Versus Inhaled Epoprostenol for Acute Pulmonary Hypertension Following Cardiac Surgery.
    McGinn K; Reichert M
    Ann Pharmacother; 2016 Jan; 50(1):22-6. PubMed ID: 26438636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Inhaled nitric oxide in the peroperative period and recovery].
    Robin E; Haddad E; Vallet B
    Ann Fr Anesth Reanim; 2002 Jul; 21(7):581-90. PubMed ID: 12192691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of inhaled nitric oxide as a selective pulmonary vasodilator in pediatric cardiac surgical practice.
    Murthy KS; Rao SG; Prakash KS; Robert C; Dhinakar S; Cherian KM
    Indian J Pediatr; 1999; 66(3):357-61. PubMed ID: 10798083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Use of oral sildenafil (Viagra) in pulmonary hypertension after cardiac pediatric surgery].
    Laquay N; Lévy ML; Vaccaroni L; Mauriat P; Carli P
    Ann Fr Anesth Reanim; 2003 Feb; 22(2):140-3. PubMed ID: 12706769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of inhaled iloprost for the management of postoperative pulmonary hypertension in congenital heart surgery patients: review of a transition protocol.
    Vorhies EE; Caruthers RL; Rosenberg H; Yu S; Gajarski RJ
    Pediatr Cardiol; 2014 Dec; 35(8):1337-43. PubMed ID: 24872141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of inhaled nitric oxide in newborn medicine.
    Golombek SG
    Heart Dis; 2000; 2(5):342-7. PubMed ID: 11728280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute and chronic effects of sildenafil in patients with pulmonary arterial hypertension.
    Preston IR; Klinger JR; Houtches J; Nelson D; Farber HW; Hill NS
    Respir Med; 2005 Dec; 99(12):1501-10. PubMed ID: 15890512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of inhaled nitric oxide and milrinone for the treatment of pulmonary hypertension in adult cardiac surgery patients.
    Solina A; Papp D; Ginsberg S; Krause T; Grubb W; Scholz P; Pena LL; Cody R
    J Cardiothorac Vasc Anesth; 2000 Feb; 14(1):12-7. PubMed ID: 10698385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent advances in pulmonary hypertension therapy.
    Ramakrishna H
    Recent Pat Cardiovasc Drug Discov; 2008 Jan; 3(1):28-36. PubMed ID: 18221126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhaled nitric oxide for children with congenital heart disease and pulmonary hypertension.
    Curran RD; Mavroudis C; Backer CL; Sautel M; Zales VR; Wessel DL
    Ann Thorac Surg; 1995 Dec; 60(6):1765-71. PubMed ID: 8787478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nitric oxide might reduce the need for extracorporeal support in children with critical postoperative pulmonary hypertension.
    Goldman AP; Delius RE; Deanfield JE; de Leval MR; Sigston PE; Macrae DJ
    Ann Thorac Surg; 1996 Sep; 62(3):750-5. PubMed ID: 8784003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous prostacyclin mitigates inhaled nitric oxide rebound effect: A case control study.
    Hermon M; Golej J; Burda G; Marx M; Trittenwein G; Pollak A
    Artif Organs; 1999 Nov; 23(11):975-8. PubMed ID: 10564300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhaled nitric oxide for pulmonary hypertension after heart transplantation.
    Ardehali A; Hughes K; Sadeghi A; Esmailian F; Marelli D; Moriguchi J; Hamilton MA; Kobashigawa J; Laks H
    Transplantation; 2001 Aug; 72(4):638-41. PubMed ID: 11544423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contribution of pulmonary surfactant with inhaled nitric oxide for treatment of pulmonary hypertension.
    Kusuda S; Kim TJ; Koriyama T; Matsunami S; Nakanishi H
    Pediatr Int; 2006 Oct; 48(5):459-63. PubMed ID: 16970783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.